发明名称 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF)
摘要 Recombinant adenoviruses comprising a heterologous DNA sequence coding for glial-derived neurotrophic growth factor (GDNF) are provided. The recombinant adenoviruses are useful in a method of expressing GDNF in a cell, wherein the cell is present in a mammal suffering from Parkinson's disease, comprising infecting said cell with a replication-defective recombinant adenovirus comprising a DNA sequence encoding GDNF operably linked to a promoter by administering the adenovirus into cells of the central nervous system. The recombinant adenoviruses of the invention are also useful in a method of treating Parkinson's disease comprising administering into cells of the central nervous system of a mammal suffering therefrom a replication defective recombinant adenovirus comprising ITRs, an encapsidation sequence and a DNA sequence encoding GDNF operably linked to a promoter, wherein the adenovirus E1 gene is non-functional and GDNF is expressed at a level that provides a therapeutic effect.
申请公布号 US6245330(B1) 申请公布日期 2001.06.12
申请号 US19960716326 申请日期 1996.10.04
申请人 AVENTIS PHARMA S.A. 发明人 HORELLOU PHILIPPE;MALLET JACQUES;PERRICAUDET MICHEL;REVAH FRéDéRIC;VIGNE EMMANUELLE
分类号 C12N15/09;A61K9/00;A61K31/70;A61K35/76;A61K38/00;A61K38/17;A61K38/27;A61K47/48;A61K48/00;A61P25/00;A61P25/28;C07H21/04;C07K14/475;C12N5/10;C12N7/00;C12N15/861;(IPC1-7):A61K48/00;C12N15/00;C12N15/88 主分类号 C12N15/09
代理机构 代理人
主权项
地址
您可能感兴趣的专利